NCT05628259

Brief Summary

This study carried out to examine the effect of tele-nursing based motivational interviewing on diabetes self-efficacy, diabetes self-management and metabolic control parameters (Body mass index, waist circumference, HbA1c%,fasting blood glucose, LDL cholesterol, HDL cholesterol, total cholesterol, triglyceride) in individuals with type 2 diabetes.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 17, 2022

Completed
11 days until next milestone

First Posted

Study publicly available on registry

November 28, 2022

Completed
2 months until next milestone

Study Start

First participant enrolled

February 1, 2023

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 2, 2023

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 2, 2023

Completed
Last Updated

March 13, 2024

Status Verified

March 1, 2024

Enrollment Period

3 months

First QC Date

November 17, 2022

Last Update Submit

March 10, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Diabetes Self-Efficacy Scale

    The change in diabetes self efficacy of individuals with Type 2 diabetes at 3rd month and 6 rd month with the Diabetes Self-Efficacy Scale.

    Change from Baseline diabetes self-efficacy at 6 months

  • Diabetes Self-Management Scale

    This scale was used to measure the behavioral component of individuals in the IMB model. The validity and reliability study of the Turkish Diabetes Self-Management Perception Scale was conducted by Eroğlu and Sabuncu (2018). The scale consists of 16 items and 4 sub-dimensions and is a 4-point Likert type. Glucose Management sub-dimension: Items 4, 6, 10, 12 (items 4 and 12 are about drug use, items 1, 6 and 10 are about blood glucose monitoring). Diet Control sub-dimension: Items 2, 5, 9, 13. Physical Activity sub-dimension: Items 8, 11, 15. Use of Health Services sub-dimension: It consists of 3, 7, 14, and 16 items. The DMS scale consists of 16 items, 7 of which are straight and 9 of which are reversed. The scores of the items numbered "5, 7, 10, 11, 12, 13, 14, 15 and 16" in the scale are calculated by reversing them. Diabetes self-management increases as the score gets closer to 10.

    Change from Baseline diabetes self-management at 6 months

Secondary Outcomes (8)

  • HbA1c%

    Change from Baseline HbA1c% at 6 months

  • BMI

    Change from Baseline Body Mass Index at 6 months

  • FBG

    Change from Baseline Fasting glucose at 6 months

  • LDL

    Change from Baseline LDL at 6 months

  • HDL

    Change from Baseline HDL at 6 months

  • +3 more secondary outcomes

Study Arms (2)

Intervention Group

EXPERIMENTAL

A motivational interview (MI) program based on the telenursing approach was applied to the individuals in the experimental group. In this study, the MI procedure includes eight sessions in total, with four sessions of motivational interviews by phone in the first month of the intervention and four sessions of motivational interviews by phone in the next two months for each individual. Pre-tests were collected in the first month. Afterwards, MI intervention was applied for three months. This intervention was applied to the experimental group in addition to the routine care provided by the hospital. MI application took an average of 45-60 minutes via phone call.

Behavioral: Tele-Nursing based Motivational Interviewing

Control Group

NO INTERVENTION

The control group received routine nursing care in the diabetes policlinic.

Interventions

A motivational interview (MI) program based on the telenursing approach was applied to the individuals in the experimental group. In this study, the MI procedure includes eight sessions in total, with four sessions of motivational interviews by phone in the first month of the intervention and four sessions of motivational interviews by phone in the next two months for each individual. Pre-tests were collected in the first month. Afterwards, MI intervention was applied for three months. This intervention was applied to the experimental group in addition to the routine care provided by the hospital. MI application took an average of 45-60 minutes via phone call.

Intervention Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \) being over 18 years old, 2) receiving insulin or insulin + oral therapy, 3) diagnosis of type 2 diabetes at least one year ago, 4) having a BMI of 25 and above, 5) HbA1c value of 7 and above, 6) access to phone, 7) voluntarily agreeing to participate in the study.

You may not qualify if:

  • \) have a physical disability.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Eda Kılınç İşleyen

Pamukkale, Denizli, (545)-561 96 83, Turkey (Türkiye)

Location

İrem Nur ÖZDEMİR

Istanbul, Turkey (Türkiye)

Location

Şengül AYDIN YOLDEMİR

Istanbul, Turkey (Türkiye)

Location

Related Publications (1)

  • Isleyen EK, Ozdemir IN, Yoldemir SA. The effect of tele-nursing based motivational interviewing on self-efficacy, self-management and metabolic control parameters in individuals with type 2 diabetes: randomized controlled study. Ir J Med Sci. 2025 Apr;194(2):563-573. doi: 10.1007/s11845-025-03916-5. Epub 2025 Feb 21.

MeSH Terms

Conditions

Hyperlipoproteinemia Type IIHypoalphalipoproteinemiasLipidoses

Condition Hierarchy (Ancestors)

Lipid Metabolism, Inborn ErrorsMetabolism, Inborn ErrorsGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesHyperlipoproteinemiasHyperlipidemiasDyslipidemiasLipid Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesHypolipoproteinemias

Study Officials

  • Eda KILINÇ İŞLEYEN, PhD. RN.

    Uşak University

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Single blinding was provided that included inclusion criteria and agreement to participate in the study.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: This study is a parallel group randomized controlled study.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Profesor Dr.

Study Record Dates

First Submitted

November 17, 2022

First Posted

November 28, 2022

Study Start

February 1, 2023

Primary Completion

May 2, 2023

Study Completion

October 2, 2023

Last Updated

March 13, 2024

Record last verified: 2024-03

Locations